| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0002-9343(00)00318-1 |
| P698 | PubMed publication ID | 10781781 |
| P2093 | author name string | K V Kowdley | |
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis | Q33745849 | ||
| Management of primary biliary cirrhosis and autoimmune cholangitis | Q35960781 | ||
| Ursodeoxycholic acid in the treatment of liver diseases | Q36727616 | ||
| Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children | Q40457634 | ||
| Ursodiol for hepatobiliary disorders | Q40664612 | ||
| Bile acid metabolism and the pathophysiology of cholestasis | Q40777957 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Clinical pharmacokinetics of therapeutic bile acids. | Q41066462 | ||
| Ursodeoxycholate increases cytosolic calcium concentration and activates CI− currents in a biliary cell line | Q41302359 | ||
| The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. | Q41464223 | ||
| Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver | Q42609313 | ||
| Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial | Q42987649 | ||
| Nonalcoholic steatohepatitis: An expanded clinical entity | Q43036189 | ||
| Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo | Q47869512 | ||
| Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. | Q50636830 | ||
| Intrahepatic cholestasis of pregnancy: a French prospective study. | Q51574209 | ||
| Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. | Q51604167 | ||
| A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection. | Q53963820 | ||
| Nonalcoholic Steatohepatitis | Q56001844 | ||
| Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease | Q68079285 | ||
| Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy | Q68134805 | ||
| Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid | Q68925952 | ||
| Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I | Q70398501 | ||
| Molecular aspects of membrane stabilization by ursodeoxycholate [see comment] | Q70457384 | ||
| Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy | Q70670255 | ||
| Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study | Q71173357 | ||
| Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis | Q71173367 | ||
| Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation | Q71586749 | ||
| Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? | Q72001802 | ||
| Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes | Q72164376 | ||
| Primary sclerosing cholangitis | Q72596376 | ||
| Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group | Q73090826 | ||
| Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study | Q73167014 | ||
| The Nordic multicenter double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients | Q73445481 | ||
| Cholestatic liver diseases in adults | Q74642704 | ||
| Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial | Q74644488 | ||
| Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression | Q74645177 | ||
| Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications | Q77598543 | ||
| The management of primary sclerosing cholangitis | Q81048479 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatobiliary disease | Q2755530 |
| P304 | page(s) | 481-6 | |
| P577 | publication date | 2000-04-15 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Ursodeoxycholic acid therapy in hepatobiliary disease | |
| P478 | volume | 108 |
| Q84088162 | A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities |
| Q42936451 | Biliary cast syndrome in an opium inhaler |
| Q42555450 | Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient |
| Q35159625 | Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells |
| Q44537944 | Determination of ursodeoxycholic acid in pharmaceutical preparations by capillary electrophoresis with indirect UV detection |
| Q34606068 | Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones |
| Q34745750 | Hepatobiliary disease in inflammatory bowel disease |
| Q33913295 | In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids |
| Q42438271 | Increased susceptibility of cholangiocytes to tumor necrosis factor-alpha cytotoxicity after bile duct ligation. |
| Q50161857 | Liraglutide-related cholelithiasis. |
| Q34422694 | Management of interferon therapy nonresponders |
| Q35644328 | Metal Zn(II), Cu(II), Ni (II) complexes of ursodeoxycholic acid as putative anticancer agents |
| Q35184131 | Nuclear receptors in cholesterol catabolism: molecular biology of the enterohepatic circulation of bile salts and its role in cholesterol homeostasis |
| Q34523863 | Parenteral nutrition-associated liver complications in children |
| Q36669314 | Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents |
| Q99564897 | Prolonged ursodeoxycholic acid administration reduces acute ischaemia-induced arrhythmias in adult rat hearts |
| Q38540846 | Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature |
| Q34506324 | Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity. |
| Q51204823 | Sex differences in the hepatic cholesterol sensing mechanisms in mice. |
| Q42326059 | Specific bile acids inhibit hepatic fatty acid uptake in mice |
| Q42168990 | Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake |
| Q34993108 | The effect of ursodeoxycholic acid in liver functional restoration of patients with obstructive jaundice after endoscopic treatment: a prospective, randomized, and controlled study |
| Q34273131 | Treatment of Nonalcoholic Fatty Liver Disease |
| Q39362065 | Treatment options for chronic cholestasis in infancy and childhood |
| Q47198958 | Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study |
| Q44471247 | Utilization of hepatoprotectants within the National Health Insurance in Taiwan |
Search more.